Retinal Vitreous Resource Center: Professional

Ongoing Research

70% Success Rate Regarding Stem Cell Research
This is an update on the extension of the work that we began on retinal transplantation with fetal tissue use in patients with dry macular degeneration and retinitis pigmentosa, which showed a success rate of 70%. (Am. J. Opthalmol 2008; 146: 172-182)

We have now, because of social ramifications with human fetal tissue and human embryonic cells, broadened our efforts to include induced pluripotent stem cell research. Human somatic cells are being genetically reprogrammed by episomal methods to become induced pluripotent stem cells (iPSC). These have been modulated to become retinal pigment epithelial cells and neural cells. These cells will be put together in layers on a collagen matrix and will then resemble the fetal tissue that we successfully transplanted into humans.

Figure 1 demonstrates the retinal pigment epithelial cells that were derived from the iPSC's that are growing successfully on a scaffolding, which is a collagen acellular matrix that is biocompatible with the cells and biodegradable.

The retinal pigment epithelial cells are shown in Figure 1-A (4x magnification of a light microscopy) covering the membrane. On the right (Figure 1-B) is a transmission electron microscopic photograph of the retinal pigment epithelial cells on top of the membrane. The nucleus, the microvilli, and basement membrane of the retinal pigment epithelial overlie the membrane, which is visible beneath the retinal pigment epithelial cells. The lower left, center, and lower right (Figure 1-C, D, and E) show immunohistochemistry of this retinal pigment epithelial cell layer, which demonstrates its cellular viability and collagen components. In summary, Figure 1 shows that the retinal pigment epithelial cells derived from the iPSC's cover the membrane and are viable.

Figure 1

Figure 2 demonstrates photoreceptors growing on the membrane. On the left (Figure 2-A) is the immunohistochemistry staining of the nuclei of the photoreceptors with Recoverin, showing that they are viable. The transmission electron microscopy on the right (Figure 2-B) shows layered photoreceptors to the left and single-layers photoreceptors over the remaining four-fifths of the photograph, which is lying on top of the membrane. The photograph shows good coverage over the membrane. The areas in the membrane that look pulled apart are artifacts of processing of the electron microscopy, not defects in the membrane.

Figure 2

These two photographs are the results of the initial steps for our future work to combine both the photoreceptors and the retinal pigment epithelial cells together on top of the collagen membrane. The next step will be to transplant this layered sheet of retinal pigment epithelial cells and photoreceptors into rats and to eventually progress to FDA approval to be used in human trials. This effort is to replicate the fetal tissue for transplantation that has been shown to be successful in our previous work in humans with dry macular degeneration and retinitis pigmentosa. This type of cell-based therapy with sheets of tissue may eventually be useful in regenerative medical therapy for dry age-related macular degeneration, retinitis pigmentosa, Stargardt's disease, rod-code dystrophy, choroideremia, gyrate atrophy, and other retinal dystrophies. This research is being done in collaboration with David Gamm, M.D., Ph.D. at the University of Wisconsin - Madison.

Download the PDF
(126K PDF document)

Retina Subspecialty Day Presentation
The following eight minute presentation was made at the Retina Subspecialty Day at the American Academy of Ophthalmology Meeting on November 7, 2008, and at the Macula of Paris Meeting in Paris, France, on January 23, 2009. It is the culmination of 15 years of ongoing research.

Watch the presentation!
(Adobe® Flash plugin required.)

Increase Text Size


Copyright © 2003-2016 The Retina Vitreous Resource Center. All rights reserved.